Sphingolipid Metabolism Is Associated with Cardiac Dyssynchrony in Patients with Acute Myocardial Infarction
AMI patients with high baseline plasma sphingomyelin/aCD ratios had a significantly increased SDI at six months. The sphingomyelin/aCD ratio can be considered as a surrogate marker of plasma ceramide load or inefficient ceramide metabolism. Plasma sphingolipid pathway metabolism may be a new biomarker for therapeutic intervention to prevent adverse remodelling after MI.
Authors
- Chia‐Chu Chang (ORCID: https://orcid.org/0000-0003-3172-8507)
- Chen‐Ling Kuo (ORCID: https://orcid.org/0000-0002-7982-9924)
- Chin‐San Liu (ORCID: https://orcid.org/0000-0001-8241-9654)
- Yu‐Shan Cheng
- Ching‐Shan Huang (ORCID: https://orcid.org/0000-0001-7221-2895)
- Ching-Hui Huang
Institutions
- Kuang Tien General Hospital (TW)
- Changhua Christian Hospital (TW)
- Chienkuo Technology University (TW)
- National Changhua University of Education (TW)
- Hungkuang University (TW)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-08-15
- DOI
- https://doi.org/10.3390/biomedicines12081864
- Citations
- 2
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.80